(Q28580328)

English

Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells

scientific journal article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

2 references

PubMed publication ID

31 January 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells (English)

2 references

PubMed publication ID

31 January 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

Akira Sugawara

1

2 references

PubMed publication ID

31 January 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Akira Uruno

2

2 references

PubMed publication ID

31 January 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Masataka Kudo

3

2 references

PubMed publication ID

31 January 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Yukio Ikeda

4

2 references

PubMed publication ID

31 January 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Kazunori Sato

5

2 references

PubMed publication ID

31 January 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Yoshihiro Taniyama

6

2 references

PubMed publication ID

31 January 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Kazuhisa Takeuchi

8

2 references

PubMed publication ID

31 January 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

language of work or name

0 references

publication date

2 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

2 references

PubMed publication ID

31 January 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

277

2 references

PubMed publication ID

31 January 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

12

2 references

PubMed publication ID

31 January 2017

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

9676-9683

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Molecular cloning of human platelet thromboxane A synthase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Increased prostacyclin and thromboxane A2 biosynthesis in atherosclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Structure and transcriptional function of the 5'-flanking region of rat thromboxane receptor gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Characterization of three RXR genes that mediate the action of 9-cis retinoic acid

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Cooperative interaction between AhR.Arnt and Sp1 for the drug-inducible expression of CYP1A1 gene.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Molecular structure and transcriptional function of the rat vascular AT1a angiotensin receptor gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking region

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Activation of the prolactin gene by peroxisome proliferator-activated receptor-alpha appears to be DNA binding-independent

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP/p300.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Diabetes mellitus: a hypercoagulable state

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Assignment of the gene for rat thromboxane receptor (Tbxa2r) to chromosome 7q11 by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Purification and biochemical characterization of the promoter-specific transcription factor, Sp1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Modifications in the TXA(2) and PGI(2) plasma levels and some other biochemical parameters during the initiation and development of non-insulin-dependent diabetes mellitus (NIDDM) syndrome in the rabbit

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Troglitazone has a reducing effect on thromboxane production

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104560200

21 January 2018

Identifiers

10.1074/JBC.M104560200

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11777901%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28580328&oldid=1811052550"